We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
+8.22%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
–
Cap. Flow
+$100M
Cap. Flow
% of AUM
100.06%
Top 10 Holdings %
Top 10 Hldgs %
20.66%
Holding
249
New
249
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$2.64M |
| 2 |
Invitation Homes
INVH
|
+$2.51M |
| 3 |
iShares MBS ETF
MBB
|
+$2.48M |
| 4 |
Euronet Worldwide
EEFT
|
+$2.17M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$2.01M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.96% |
| 2 | Technology | 10.32% |
| 3 | Real Estate | 9.94% |
| 4 | Industrials | 7.65% |
| 5 | Financials | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
26
DELISTED
Avadel Pharmaceuticals
AVDL
| $812K | 0.81% |
+37,693
| New | +$732K |
|
27
Intuitive Machines
LUNR
$2.17B
| $812K | 0.81% |
+50,000
| New | +$579K |
|
28
Apogee Therapeutics
APGE
$10.1B
| $811K | 0.81% |
+10,751
| New | +$677K |
|
29
Richtech Robotics
RR
$358M
| $808K | 0.8% |
+250,000
| New | +$1.11M |
|
|
EXAS
30
DELISTED
Exact Sciences
EXAS
| $802K | 0.8% |
+7,901
| New | +$634K |
|
31
Procept Biorobotics
PRCT
$1.09B
| $787K | 0.78% |
+25,000
| New | +$829K |
|
|
SERV
32
Serve Robotics
SERV
$433M
| $779K | 0.78% |
+75,000
| New | +$901K |
|
33
Rockwell Automation
ROK
$51.4B
| $778K | 0.78% |
+2,000
| New | +$752K |
|
34
Globus Medical
GMED
$10.5B
| $761K | 0.76% |
+8,712
| New | +$661K |
|
35
Protagonist Therapeutics
PTGX
$9.06B
| $747K | 0.74% |
+8,549
| New | +$700K |
|
36
Symbotic
SYM
$5.25B
| $744K | 0.74% |
+12,500
| New | +$825K |
|
37
Amgen
AMGN
$198B
| $721K | 0.72% |
+2,202
| New | +$698K |
|
38
Ascendis Pharma A/S
ASND
$17.1B
| $690K | 0.69% |
+3,238
| New | +$669K |
|
39
AbbVie
ABBV
$450B
| $681K | 0.68% |
+2,979
| New | +$679K |
|
|
AEVA
40
Aeva Technologies
AEVA
$1.14B
| $664K | 0.66% |
+50,000
| New | +$712K |
|
|
AAT
41
American Assets Trust
AAT
$1.57B
| $663K | 0.66% |
+35,000
| New | +$676K |
|
42
Sanofi
SNY
$107B
| $659K | 0.66% |
+13,594
| New | +$674K |
|
43
Biogen
BIIB
$30.4B
| $638K | 0.64% |
+3,627
| New | +$593K |
|
44
Unusual Machines
UMAC
$809M
| $637K | 0.63% |
+50,000
| New | +$586K |
|
45
SoundHound AI
SOUN
$2.73B
| $623K | 0.62% |
+62,500
| New | +$899K |
|
|
SMA
46
SmartStop Self Storage REIT
SMA
$1.9B
| $619K | 0.62% |
+20,000
| New | +$677K |
|
47
AeroVironment
AVAV
$7.2B
| $605K | 0.6% |
+2,500
| New | +$786K |
|
48
iShares MSCI Australia ETF
EWA
$1.43B
| $596K | 0.59% |
+22,763
| New | +$602K |
|
49
JPMorgan BetaBuilders Japan ETF
BBJP
$17.1B
| $595K | 0.59% |
+9,030
| New | +$614K |
|
50
Synopsys
SNPS
$73.6B
| $587K | 0.59% |
+1,250
| New | +$555K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for AlphaCentric Advisors, which disclosed 249 positions worth $100M. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Gilead Sciences: 21,761 shares worth $2.67M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, followed by Technology and Real Estate.
- AlphaCentric Advisors's largest Q4 2025 buy was Gilead Sciences: 21,761 shares worth $2.67M.
- AlphaCentric Advisors's ten largest holdings make up 21% of its $100M portfolio in Q4 2025.
- AlphaCentric Advisors disclosed 249 positions in Q4 2025, its first 13F filing on record.
Based on AlphaCentric Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.